HOME >> BIOLOGY >> NEWS
Gene therapy holds promise for treating inherited Lou Gehrig's Disease

CHICAGO --- Using gene therapy in laboratory mice, researchers have halted motor neuron destruction and slowed progression of inherited amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, a lethal, progressive neurological disorder that renders the muscles of the body useless while leaving the mind unaffected.

This finding suggests that a similar gene therapy approach might someday prove effective in treating humans with ALS, according to Northwestern University developmental neurobiologist Martha C. Bohn and colleagues in an article in the July 15 issue of Human Gene Therapy.

Bohn is a professor of pediatrics at Northwestern University Medical School and director of the neurobiology program at Children's Memorial Institute for Education and Research.

Into the hindlimbs of an ALS mouse model, Bohn and co-researchers injected young skeletal muscle cells (myoblasts) infected with a virus that had been made harmless and also engineered to carry the gene for glial cell-derived neurotrophic factor (GDNF). GDNF is a protein that has been found to block nerve cell degeneration in animal models of Parkinson's disease.

The GDNF gene therapy enhanced survival of motor neurons in the laboratory model of inherited ALS and increased the number of motor neurons that maintained 'communication' with cells in treated leg muscles. Additionally, GDNF gene therapy slowed shrinkage of motor neurons and muscle atrophy, improved motor function in affected mice and delayed onset of ALS disease symptoms.

"The most critical issues in designing a gene therapy approach for any human disease are to have a good animal model of the disease and to choose the appropriate target tissue and mode of gene delivery," Bohn said.

The mice used in this study express a mutant gene that is carried by humans with a hereditary form of ALS. These mice were developed by Mark Gurney and Teepu Siddique, professor of neuro
'"/>

Contact: Elizabeth Crown
e-crown@nwu.edu
312-503-8928
Northwestern University
19-Jul-1999


Page: 1 2 3

Related biology news :

1. Targeted therapy knocks out pediatric brain cancer in mice
2. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
3. Columbia research to examine gene influence on severity of peridontal disease, therapy response
4. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
5. The search for a kinder, gentler chemotherapy
6. Embryonic stem cell therapy shows steady benefits in rebuilding infarcted heart
7. Retroviral gene therapy? ASLV, HIV, and MLV show distinct target site preferences
8. Gene changes linked to increased eye pressure may have implications for glaucoma therapy
9. Jefferson Lab detector technology aids development of cystic fibrosis therapy
10. Stroking up cellular therapy
11. Smart gene therapy protects against damage from heart attack

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/19/2019)... YORK (PRWEB) , ... November 19, 2019 , ... The ... Plaza Times Square in New York City. The one-day event will be chaired by ... group of leaders in the space. , “We are witnessing significant innovation in ...
(Date:11/14/2019)... ... November 13, 2019 , ... NDA Partners Chairman ... regulatory affairs and program management executive with more than 33 years of regulatory ... the firm as an Expert Consultant. , Robert Peterson has extensive experience ...
(Date:11/12/2019)... ... November 12, 2019 , ... ... medical devices, today announced the creation of a Global Regulatory Affairs Department, to ... Device industry is that the regulatory element to any Medtech organization is more ...
Breaking Biology News(10 mins):
(Date:12/2/2019)... ... ... Registration is now open for the American Society of Gene & Cell ... May 12-15, 2020, in Boston. The meeting is the premier event in the field ... stakeholders with the goal of advancing gene and cell therapies to alleviate human disease. ...
(Date:11/20/2019)... ... November 20, 2019 , ... ... of about 8,500 microturbine electrical power generation units from 2019-2028. The value of ... over 2017's projection of 3,821 units worth $569 million. , Reference to ...
(Date:11/12/2019)... Wis. (PRWEB) , ... November 12, 2019 , ... ... food ingredient solutions for the food and beverage industry launched a new innovative ... improve the digital experience. Now, the website offers global visitors updated ingredient usage ...
(Date:11/6/2019)... ... ... Diversified Technologies, Inc. has introduced a PEF production system for ... processing. , The DTI Industrial PEF Unit can pre-treat whole pieces of fruits and ... up to 50% and achieve up to an 80% reduction of drying energy. ...
Breaking Biology Technology:
Cached News: